Clinical Trials Logo
  1. Home
  2. Cocaine Use
  3. NCT01631383

Pharmacokinetic and Safety Evaluation of L-tetrahydropalmatine (l-THP) With Cocaine Exposure in People With a History of Cocaine Use

Cocaine Use Clinical Trial

Official title:
Pharmacokinetic and Safety Evaluation of L-tetrahydropalmatine (l-THP) With Cocaine Exposure in People With a History of Cocaine Use

Clinical Trial Summary

This study will test the safety and pharmacokinetic profile of l-THP with cocaine exposure in people who have a history of cocaine use. The subject will be admitted to the Brief Stay Unit (BSU), an inpatient facility at the Maryland Psychiatric Research Center, used for short term drug abuse or clinical trial studies. The participant will stay for 4 nights and 5 days. He/she will be randomized to either placebo or l-THP for three days. On the morning of Day 4, the subject will receive one cocaine dose (40 mg intranasal) and have testing for pharmacokinetic parameters for the following 10 hours. The subject will stay over one more night and will be discharged the following day. Approximately 40 subjects will be randomized to enroll the target sample of 30 (N=15 placebo, N=15 l-THP). In summary, each subject will come for a screening visit(s), then a 5-day, 4-night stay on a secure research unit. After cocaine administration day, the participant will stay overnight for one more day of observation and to permit substantial l-THP elimination from the body. The following morning we will get one additional blood specimen for l-THP (Day 5 at 24 hours after last dose (7:30 am); then the participant will be discharged. A visit with blood collection on Day 6 at 55 hours after last dose (2:30 pm) will be scheduled. A final follow-up visit will be scheduled 4-7 days after unit discharge to ensure no persisting side effects.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01631383
Study type Interventional
Source University of Maryland, Baltimore
Contact
Status Completed
Phase Phase 1
Start date October 2012
Completion date June 2017
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT02139761 - L-tetrahydropalmatine (l-THP) Treatment for Cocaine Use Disorder Phase 2
Not yet recruiting NCT05974202 - rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder Phase 2
Recruiting NCT04927143 - Encouraging Abstinence Behavior in a Drug Epidemic Phase 2
Active, not recruiting NCT05809453 - Intranasal Cocaine and Temperature Regulation During Exercise Phase 1/Phase 2
Completed NCT01851473 - Interactions Between Intravenous Cocaine and Acetazolamide or Quinine Phase 1
Completed NCT04061941 - Change in Cognitive Function in Stimulant Users
Withdrawn NCT01222806 - Pilot Study of Repetitive Transcranial Magnetic Stimulation in Cocaine Craving Phase 1
Recruiting NCT06177860 - Clinical and Atherosclerotic Characteristics of Patients With ACS Associated With Cocaine Use
Completed NCT04418076 - Project SMART Automated Pillbox Study N/A
Recruiting NCT05766631 - Treating Polysubstance Use Using a Novel Digital Technology Phase 3
Enrolling by invitation NCT05704764 - Using the Ending Self-Stigma Intervention to Reduce Internalized Stigma Among People Living With HIV Who Use Substances N/A
Not yet recruiting NCT06045793 - Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST) Phase 2
Not yet recruiting NCT05824221 - Effect of rTMS on Neurotrophines Levels in CUD N/A